FINNENCE▪
00:00:00 UTCSYS ONLINE
FINNENCE ▪ THE WIRE FILE

THE WIRE · № 81058

News■ Unclear/unknown

Iambic Therapeutics prices IPO at $16 per share on Nasdaq

KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES2
STORY SIZE7 RECORDS
FIRST SEEN
LAST UPDATE
STATEactive

01 THE MACHINE READ

WHY IT MATTERS.

An IPO pricing at $16 is a small-cap listing with limited read-through to broader healthcare.

Minor biotech IPO, narrow relevance
CATALYST TO WATCH

First-day trading performance

MAIN RISK

Post-IPO price weakness

02 THE STORY SO FAR

THE RECORD, IN ORDER.

UPDATED 7 TIMES · FIRST · LAST
2026-10-14 23:08 UTCNewsIambic Therapeutics prices IPO at $16 per share on NasdaqCURRENT RECORD
2026-10-15 00:13 UTCNewsIambic, an AI drug discovery specialist, banks $150M in an IPO
2026-10-15 06:07 UTCNewsIAM IPO News - Small molecule biotech Iambic Therapeutics prices IPO at $16, the midpoint of the range
2026-10-15 06:30 UTCNewsIambic goes public with $150M IPO to accelerate clinical development of oncology pipeline
2026-10-15 08:18 UTCNewsIambic Therapeutics prices 9.38M share IPO at $16.00/share
2026-10-15 11:55 UTCNewsIambic Therapeutics sets $16 IPO price, targets $150 million raise
2026-10-15 14:04 UTCNewsIambic banks $150M from IPO to advance cancer pipeline

03 WHO'S INVOLVED

ENTITIES ON FILE.

AFFECTEDHealthcare

04 RECEIPTS

THE SOURCE RECORD.

1 SOURCES CONFIRMED
№ 01googlenewsnews.google.com · PRIMARY2026-10-14 23:08 UTCOPEN RECEIPT →

05 PROPAGATION

WHAT THIS TOUCHES.

KEEP READING THE MACHINE

OPEN THE MACHINE →THE PREDICTION LEDGER →

Summaries are generated and may contain errors — every claim links its sources.